Riboscience LLC

Riboscience develops treatments targeting human disease at the molecular level, particularly in oncology and virology, using ribose-based molecules.

3 documented relationships

Hover or select an entity to isolate its relationships. Link thickness reflects the documented amount.

Detailed register

Peter N. CrnkovichAdvisory roleRiboscience LLC
Reported^{2BioTheryX, Inc. Announces the Appointment of BioPharma Finance Veteran Peter N. Crnkovich to Board of Directorsbiotheryx.com}
Position or item indicated by the source: “Senior Advisor”.
Klaus KlumppEmploymentRiboscience LLC
Reported^{3Riboscience - 2026 Company Profile & Team - Tracxntracxn.com}^{4About — Riboscience LLCriboscience.com}^{5Klaus Klumpp — Riboscience LLCriboscience.com}^{6Klaus Klumpp | CAMPPcampp.org}
Role or title indicated by the source: “Co-Founder & President”.
Klaus KlumppBoard seatRiboscience LLC
Reported^{4About — Riboscience LLCriboscience.com}
Role or object indicated by the source: “Founder and President”.

Sources

1.
Riboscience | Pioneering RNA Therapeutics and Precision Medicine Innovation
Web pageriboscience.com
View original ↑ Back to text
2.
BioTheryX, Inc. Announces the Appointment of BioPharma Finance Veteran Peter N. Crnkovich to Board of Directors
Web pagebiotheryx.com
View original ↑ Back to text
3.
Riboscience - 2026 Company Profile & Team - Tracxn
Web pagetracxn.com
View original ↑ Back to text
4.
About — Riboscience LLC
Web pageriboscience.com
View original ↑ Back to text
5.
Klaus Klumpp — Riboscience LLC
Web pageriboscience.com
View original ↑ Back to text
6.
Klaus Klumpp | CAMPP
Web pagecampp.org
View original ↑ Back to text